Galacto-Oligosaccharides Market Size - Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2025 - 2034

Galacto-Oligosaccharides Market Size

The global galacto-oligosaccharides (GOS) market generated notable revenues in 2024 and is estimated to grow at a CAGR during 2025-2034, driven by the demand from consumers seeking prebiotics in functional ingredients in foods or health-focused products. GOS is a type of prebiotic fiber recognized for its positive impact on gut health, as it favors the growth of beneficial bacteria (bifidobacteria). As consumers and an older demographic globally are becoming increasingly aware and interested in digestive health, we expect GOS to be implicated in an increasing number of downstream applications relevant to both infant nutrition and adult dietary supplements. GOS is a non-digestible fiber and can traverse the gastrointestinal tract to the colon, where GOS would facilitate microbial diversity and impact intestinal health.

The increased incidence of lifestyle-related diseases such as irritable bowel syndrome (IBS), constipation, and obesity is driving the acceptance of greater GOS-rich diets and supplements. As per NIH.gov, approximately 10% to 23% of adults globally have been affected by irritable bowel syndrome (IBS). The usage and success of GOS reach further than just aiding digestion: as GOS continues to be shown to be beneficial to immunity, calcium absorption, and mental health, they continue to appeal to a wider audience. Improved extraction processes and stability, and the increasing popularity of veganism and clean labels, are likely to contribute to market growth and penetration. However, the market must also face certain restraints.
 

High production costs associated with the enzymatic synthesis of GOS and production scale, as well as the downstream processing steps, could also impact the pricing and scale-up scalability of GOS. Also, health claim regulations and approval processes across many regions could impact the speed of launching their products into the market. Contrarily, consumer skepticism in some regions of whether prebiotics have health benefits may impact consumers' willingness to adopt GOS products. Still, the outlook is positive because research continues to demonstrate the benefits of GOS, and companies are doing their part to expand their innovation and education, to help alleviate the market's limitations.
 

Galacto-Oligosaccharides Market Trends

The GOS market landscape is changing quickly because of evolving consumer behaviors, technological advancements, and innovation. One major trend is the rise in plant-based foods and clean-label ingredients. As a result, we are witnessing changes in manufacturers from using other sources of GOS, free from dairy sources, to be able to meet the needs of lactose-intolerant and vegan consumers. Another trend developing is the use of GOS in sports active nutrition and functional beverages, with increasing interest from athletes and those involved in fitness products that are formulating products for providing digestive assistance and availability of nutrients to the body.
 

GOS products formulated for sports nutrition and active living may assist with these issues. There is an increased use of GOS with probiotics to develop synbiotic products, which are being used for both food applications and pharmaceuticals, providing an enhanced pro-prebiotic solution for the microbiota of gut health. The developments in the technology of fermentation and enzymatic hydrolysis are also making GOS production more cost-effective and sustainable. Furthermore, GOS is being studied for its potential neuroprotective properties and the implications for the gut-brain axis will drastically improve the possibilities of GOS for cognitive and brain health products.
 

Galacto-Oligosaccharides Market Analysis

The syrup-type segment in the galacto-oligosaccharides industry is expected to remain the largest segment through 2034. GOS, as a syrup, can be used across several applications but is most prevalently used in infant formula products, dairy products, beverages, and nutraceuticals because of its solubility and ease of proportion into liquid-enabled formulations (any form of a beverage or semi-solid product). Most often GOS syrup is more manageable and preferred for many commercial applications because of its desirable physical properties.
 

From a formulation perspective, manufacturers prefer GOS syrups because GOS syrup forms are considered stable during processing and compatible with a wide variety of forms or types of ingredients, including what is mostly used in beverages and yogurt-like products.  GOS syrup products can deliver the same functional capabilities as powder forms, such as promoting mineral absorption and providing prebiotic support for gut biota in addition to many possible applications. The trend in additional interest in GOS syrup products continues as consumer demand for health drinks (including functional drinks) and ready-to-drink functional nutritional base products grows.
 

The food & beverage segment in the galacto-oligosaccharides (GOS) market is expected to grow significantly through 2034. GOS has appeared in dairy products, baked goods, beverages, cereal, and snack foods, and continues to grow in use due to the rise in demand for gut health ingredients and functional food. Infant formula is an especially resilient subsegment in this category, especially with the accepted science behind GOS in mimicking oligosaccharides found in human milk, with possible outcomes of improved gut health and better immunity during infancy.  In adult nutrition, foods containing GOS are increasingly accepted by consumers who are scanning ingredients for digestive support and preventative health aspects.
 

The growing number of consumers who read labels and are buying foods with recognized health claims makes GOS an obvious ingredient choice for manufacturers. Manufacturers are recognizing that GOS works with multiple options of processing and using GOS they can use it in shelf-stable and fresh products. Functional foods and fortified foods have become increasingly common among consumers, and GOS sales are likely to follow a consistent upward trend when looking at larger trends within the food and beverage industry such as plant-based, clean-label, and higher-fibre options.
 

Europe galacto-oligosaccharides market will continue to dominate throughout 2034. The region benefits substantially from strong government support for prebiotics, and the populace has a high understanding of digestion and microbiomes, health, and wellness references. Germany, France, the Netherlands, and the UK have experienced significant uptake of functional food products resulting in outstanding GOS growth. The European Food Safety Authority (EFSA) has established a framework that allows the introduction and advertisement of prebiotics in foods with high scientific validity.
 

 Europe also has an established dairy and infant nutrition parents sector in which GOS is a key ingredient. The available purchasing power of consumers and their ever-growing health-focused ingredient consciousness are contributing factors to strong market development. European manufacturers have high levels of technology and innovation within food which has meant substantial investment into R&D regarding gut health and personalized nutrition.
 

Galacto-Oligosaccharides Market Share

Major players galacto-oligosaccharides industry include:

• Clasado BioSciences
• Yakult Pharmaceutical Industry
• Kerry Group
• Ingredion
• FrieslandCampina (Zuivelcooperatie FrieslandCampina U.A.)
• Samyang (Jeon Jung Yoon)
   

To strengthen the market presence of GOS, players in the GOS landscape need to adopt creative approaches using external capabilities, innovate new products, and expand in new fresh growth markets and geographies. Many players in the GOS landscape are making large investments in research and development as they pursue new applications in non-digestive applications like immunity, bone health, and cognitive function. For GOS producers, collaborations with food and pharmaceutical companies make it easier to create much broader portfolios with health-enhancing ingredients.
 

GOS producers are also experimenting with a wider range of GOS products - from plant-based or non-dairy versions, they are attempting to tap into the vegan and lactose-intolerant markets as well. From a GOS perspective, larger players in the GOS landscape are creating efficiency in logistics and supply chains and sustainable production methods for environmental consumers. While established from a scientific basis and meaningful health benefits, great branding, and consumer education will be necessary to establish credibility with consumers.
 

Galacto-Oligosaccharides Industry News

In January 2024, FrieslandCampina stated that Thai authorities approved its 2’-fucosyllactose ingredients for use in infant and follow-up formulas. It was already cleared for flavored milk drinks for kids over three and was used in products for infants and young children. This approval made them the only supplier of both HMOs and GOS in Thailand.